Accueil
Détail de l'auteur
Documents disponibles écrits par cet auteur (5)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Article : Périodique
L. DEGENHARDT ; B. CLARK ; G. MACPHERSON ; O. LEPPAN ; S. NIELSEN ; E. ZAHRA ; B. LARANCE ; J. KIMBER ; D. MARTINO-BURKE ; M. HICKMAN ; M. FARRELL |Background: Opioid dependence is associated with substantial health and social burdens, and opioid agonist treatment (OAT) is highly effective in improving multiple outcomes for people who receive this treatment. Methadone and buprenorphine are [...]
Article : Périodique
B. LARANCE ; L. DEGENHARDT ; N. LINTZERIS ; A. WINSTOCK ; R. MATTICK |AIMS: This paper (i) reviews the language used to describe and manage those patient practices that fall outside standard medical models of opioid treatment (for pain and opioid dependence), and (ii) proposes a consistent terminology that can be [...]
Article : Périodique
Principaux messages : 1. La méthadone pourrait maintenir plus de personnes en traitement que la buprénorphine. 2. Les personnes ont rapporté consommer moins d'opioïdes avec la méthadone qu'avec la buprénorphine, bien que les analyses d'urine p[...]
Article : Périodique
B. OSBORNE ; B. LARANCE ; R. IVERS ; F. P. DEANE ; L. D. ROBINSON ; P. J. KELLY |ISSUES: Substance use disorders are associated with significant physical health comorbidities, necessitating an integrated treatment response. However, service fragmentation can preclude the management of physical health problems during addictio[...]
Article : Périodique
D. HORYNIAK ; P. DIETZE ; B. LARANCE ; A. WINSTOCK ; L. DEGENHARDT |BACKGROUND Diversion and injection of buprenorphine (Subutex®) and buprenorphine-naloxone (Suboxone®) have been well documented. Recent international research and local anecdotal evidence suggest that these medications are also used by other rou[...]
